Myriad Genetics
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Diagnostics & Research
業務概覽 Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
公司地址 322 North 2200 West, Salt Lake City, UT, USA, 84116
電話號碼 +1 801 584-3600
傳真號碼 +1 801 584-3640
公司網頁 https://www.myriad.com
員工數量 2700
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Samraat S. Raha President, Chief Executive Officer and Director 美元 856.90K 14/04/2026
Mr. Mark S. Verratti Chief Operating Officer 美元 622.88K 14/04/2026
Ms. Shereen Solaiman Chief People Officer -- 14/04/2026
Mr. Dale Muzzey Chief Scientific Officer 美元 506.40K 14/04/2026
Mr. Benjamin R. Wheeler Chief Financial Officer and Principal Accounting Officer 美元 408.49K 14/04/2026
Ms. Jennifer Fox Chief Legal Officer -- 14/04/2026
Mr. Brian J. Donnelly Chief Commercial Officer 美元 350.00K 14/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. Heiner Dreismann,PhD Independent Director 14/04/2026
Mr. Mark S. Davis Independent Director 14/04/2026
Ms. S. Louise Phanstiel Chairman of the Board 14/04/2026
Mr. Samraat S. Raha President, Chief Executive Officer and Director 14/04/2026
Dr. Daniel M. Skovronsky, M.D.,PhD Independent Director 14/04/2026
Ms. Colleen F. Reitan Independent Director 14/04/2026
Dr. Lee N. Newcomer, M.D. Independent Director 14/04/2026
Ms. Rashmi Kumar Independent Director 14/04/2026
Mr. Paul M. Bisaro Independent Director 14/04/2026
 
所屬ETF (更新日期: 02/05/2026 04:22)
代號 名稱 佔比% ▼ 持有日期
EKGFirst Trust Nasdaq Lux Dgtl Hlth SoluETF<0.000001%21/09/2025
ESGVVanguard ESG US Stock ETF<0.000001%30/09/2025
ESIXState Street® SPDR® S&P SmCap 600 ESGETF<0.000001%23/03/2026
EWSCInvesco S&P SmallCap 600® Equal Wt ETF<0.000001%20/03/2023
GINNGoldman Sachs Innovate Equity ETF<0.000001%23/02/2026
HKNDHumankind US Stock ETF<0.000001%24/11/2025
IJRiShares Core S&P Small-Cap ETF<0.000001%20/03/2026
IJSiShares S&P Small-Cap 600 Value ETF<0.000001%20/03/2026
IJTiShares S&P Small-Cap 600 Growth ETF<0.000001%20/03/2026
JMEEJPMorgan Small & Mid Cap Enh Eq ETF<0.000001%15/04/2026
MMTMState Street® SPDR® S&P® 1500MomtTiltETF<0.000001%23/03/2026
OMFSInvesco Russell 2000® Dynamic Mltfct ETF<0.000001%08/04/2026
PSCHInvesco S&P SmallCap Health Care ETF<0.000001%23/03/2026
PWSPacer WealthShield ETF<0.000001%13/03/2026
QVMSInvesco S&P SmallCp 600 QVM Mlt-fctr ETF<0.000001%22/09/2025
RFLRInnovator U.S. Small Cp Mgd Flr ETF<0.000001%05/03/2026
RWJInvesco S&P SmallCap 600 Revenue ETF<0.000001%23/03/2026
SAAProShares Ultra SmallCap600<0.000001%23/03/2026
SLYGState Street® SPDR® S&P 600™ Sm Cp GrETF<0.000001%23/03/2026
SLYVState Street® SPDR® S&P 600™ Sm CpValETF<0.000001%23/03/2026
  1    2    3   4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.